ebola virus

How We Used Machine Learning to Investigate Where Ebola May Strike
How We Used Machine Learning to Investigate Where Ebola May Strike
ProPublica
Public Health
ProPublica
ebola virus
machine learnings
artificial intelligence
Flag link:
US FDA approves Merck’s Ebola vaccine for under-18s
US FDA approves Merck’s Ebola vaccine for under-18s
Pharmaceutical Technology
Merck
ebola virus
vaccines
Ervebo
pediatric
Flag link:
HHS to Back Emergent BioSolutions’ Ebola Drug Development With Potential $704M Award
HHS to Back Emergent BioSolutions’ Ebola Drug Development With Potential $704M Award
GovConWire
Emergent BioSolutions
HHS
ebola virus
Flag link:
Inovio reports new data for Ebola booster vaccine
Inovio reports new data for Ebola booster vaccine
Clinical Trials Arena
Inovio
vaccines
clinical trials
ebola virus
Flag link:
Inovio hopes Ebola vaccine booster data can provide a shot in the arm
Inovio hopes Ebola vaccine booster data can provide a shot in the arm
Fierce Biotech
Inovio
ebola virus
vaccines
clinical trials
Flag link:
Ebola vaccine built on same technology as Covid-19 jab from J&J shows long-lasting success
Ebola vaccine built on same technology as Covid-19 jab from J&J shows long-lasting success
Endpoints
JNJ
vaccines
ebola virus
Flag link:
Johnson & Johnson donates Ebola vaccine amid new outbreak
Johnson & Johnson donates Ebola vaccine amid new outbreak
Endpoints
JNJ
vaccines
ebola virus
Flag link:
FDA greenlights second Ebola treatment in three months, handing new OK to Ridgeback's Ebanga
FDA greenlights second Ebola treatment in three months, handing new OK to Ridgeback's Ebanga
Endpoints
ebola virus
Ridgeback Biotherapeutics
Ebanga
FDA
Flag link:
FDA approves Regeneron antibody drug as first Ebola virus treatment
FDA approves Regeneron antibody drug as first Ebola virus treatment
BioPharma Dive
Regeneron
FDA
antibodies
ebola virus
Flag link:
5 FDA approval decisions to watch in the 4th quarter
5 FDA approval decisions to watch in the 4th quarter
BioPharma Dive
FDA
drug approvals
vaccines
Pfizer
Moderna Therapeutics
COVID-19
Regeneron
EB3
ebola virus
Alkermes
ALKS-3831
schizophrenia
bipolar disorder
Bristol-Myers Squibb
liso-cel
non-Hodgkin lymphoma
roxadustat
FibroGen
chronic kidney disease
Flag link:
J&J’s Ebola vaccine approved in EU
J&J’s Ebola vaccine approved in EU
Pharmaforum
Europe
JNJ
ebola virus
Janssen
vaccines
Bavarian Nordic
Flag link:
Merck's Ebola Vaccine Approved for Use in Four African Countries
Merck's Ebola Vaccine Approved for Use in Four African Countries
Motley Fool
Merck
Africa
vaccines
Ervebo
ebola virus
Congo
Ghana
Zambia
Burundi
Flag link:
‘Against all odds’: The inside story of how scientists across three continents produced an Ebola vaccine
‘Against all odds’: The inside story of how scientists across three continents produced an Ebola vaccine
Stat
ebola virus
vaccines
WHO
Merck
Flag link:
Following Merck approval, Gavi authorizes $178M to build Ebola vaccine stockpile
Following Merck approval, Gavi authorizes $178M to build Ebola vaccine stockpile
Fierce Pharma
Merck
vaccines
ebola virus
Ervebo
GAVI
Flag link:
The Ebola Vaccine Is Now Officially Here With Approval In Europe
The Ebola Vaccine Is Now Officially Here With Approval In Europe
Forbes
Europe
ebola virus
vaccines
Merck
Ervebo
Flag link:
J&J's Experimental Ebola Vaccine to be Deployed in the Congo to Help Stem Outbreak
J&J's Experimental Ebola Vaccine to be Deployed in the Congo to Help Stem Outbreak
BioSpace
JNJ
Congo
vaccines
WHO
ebola virus
Flag link:
CHMP backs world’s first Ebola vaccine from Merck, NewLink
CHMP backs world’s first Ebola vaccine from Merck, NewLink
Pharmaforum
Merck
ebola virus
vaccines
CHMP
EMA
Europe
NewLink Genetics
Flag link:
Congo to start using J&J Ebola vaccine in November
Congo to start using J&J Ebola vaccine in November
Yahoo/Reuters
Congo
JNJ
ebola virus
vaccines
Flag link:
Merck's Ebola vaccine tees up FDA date, aiming for first status
Merck's Ebola vaccine tees up FDA date, aiming for first status
Fierce Biotech
Merck
ebola virus
vaccines
FDA
V920
Flag link:
HHS pledges $23M to develop Merck's experimental Ebola vaccine
HHS pledges $23M to develop Merck's experimental Ebola vaccine
Beckers Hospital Review
HHS
vaccines
Merck
V920
ebola virus
Flag link:

Pages